Rapid advancements in genomics have brought a better understanding of molecular mechanisms for various pathologies and identified a number of highly attractive target classes. By pushing the boundaries of drug design and discovery through innovative advances in peptide biology, engineering, and production, peptides are becoming one of the most promising classes of potential novel therapeutics through their ability to selectively modulate key biological pathways. The 2020 Chemistry and Biology of Peptides Gordon Research Conference will showcase the most recent, cutting edge research in advancing peptides as tools, materials, and therapeutics.
We are dedicated to bridging ideas from academia with the cutting edge in biotechnology and translation. The 2020 program will feature invited talks from academic and industry leaders in the field from around the world, poster sessions and, in the GRC tradition, plenty of time for discussion and scientific exchanges to continue to build the peptide-science community. To engage early career scientists and foster the discussion of new frontiers, this year's program will also highlight rising stars in peptide science. The GRC has several programs to encourage and support attendance by underrepresented groups, from whom we endorse and encourage applications.
Following the success of past meetings, the 2020 GRC will also be preceded by a GRS organized by young researchers, and a GRC Power Hour for men and women attendees to discuss topics surrounding diversity and inclusion in the sciences.
The conference will consist of nine sessions, on the topics listed below. The conference chair is currently developing their preliminary program, which will include the names of the invited speakers and discussion leaders for each of these sessions. Please check back regularly for updates to this information.
- Keynote Session: Peptide Engineering and Biology
- Chemical Biology of Peptides
- Peptide Chemistry, Synthesis and Biosynthesis
- Peptide Materials
- Computational Peptide Design
- Peptide Pathologies and Vaccines
- Peptide Libraries and Lead Discovery
- Peptide Therapeutics, from Clinical Trials to Market
- New Tools and Resources to Understand Peptides